481181
銀(I)スルファジアジン
98%
別名:
スルファジアジン銀
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
実験式（ヒル表記法）:
C10H9AgN4O2S
CAS番号:
分子量:
357.14
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
244-834-5
MDL number:
Assay:
98%
Form:
powder
Quality Level
assay
98%
form
powder
reaction suitability
core: silver
mp
285 °C (dec.) (lit.)
application(s)
PEM fuel cells
material synthesis precursor
SMILES string
Nc1ccc(cc1)S(=O)(=O)N([Ag])c2ncccn2
InChI
1S/C10H9N4O2S.Ag/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;/h1-7H,11H2;/q-1;+1
InChI key
UEJSSZHHYBHCEL-UHFFFAOYSA-N
Application
Silver(I) sulfadiazine (AgSD) is popularly used for treating second-degree burn wounds as it acts as an antimicrobial agent and prevents infections. Silver sulfadiazine-impregnated polyurethane (PU) foam, chitosan/chondroitin sulfate films may be used for wound dressing.
保管分類
11 - Combustible Solids
wgk
WGK 2
資料
Plasmonic nanoparticles have unique optical properties that can be tailored to suit a variety of applications in the biotechnology1–8 and electronics9–16 industries.
金ナノロッド合成法に関する、よくある落とし穴とその最善の回避方法について解説します。
Daniel J Ostlie et al.
Journal of pediatric surgery, 47(6), 1204-1207 (2012-06-19)
The 2 most commonly used topical agents for partial thickness burns are silver sulfadiazine (SSD) and collagenase ointment (CO). Silver sulfadiazine holds antibacterial properties, and eschar separation occurs naturally. Collagenase ointment is an enzyme that cleaves denatured collagen facilitating separation
Annette Downe
British journal of community nursing, Suppl, S32-S32 (2013-05-21)
This product focus seeks to give an overview of the management of wound bioburden in relation to the use of antimicrobial dressings, according to recent guidelines and best practice statements. Identification of critical colonisation/localised infection and the role of biofilms
Luísiane de Ávila Santana et al.
Ultrasonics, 53(4), 870-879 (2013-01-09)
The immunological mechanisms that are triggered by Low-Intensity Pulsed Ultrasound (LIPUS) in wound healing are unknown. In the present study, experimental groups were used to assess the treatment of chronic venous ulcers with 30mW/cm(2) SATA peripheral LIPUS three times per